Environmental risk assessment for the serotonin re-uptake inhibitor fluoxetine: Case study using the European risk assessment framework
Version of Record online: 1 APR 2010
Copyright © 2010 SETAC
Integrated Environmental Assessment and Management
Special Issue: Environmental Risk Assessment of Pharmaceuticals (ERAPharm)
Volume 6, Issue S1, pages 524–539, July 2010
How to Cite
Oakes, K. D., Coors, A., Escher, B. I., Fenner, K., Garric, J., Gust, M., Knacker, T., Küster, A., Kussatz, C., Metcalfe, C. D., Monteiro, S., Moon, T. W., Mennigen, J. A., Parrott, J., Péry, A. R., Ramil, M., Roennefahrt, I., Tarazona, J. V., Sánchez-Argüello, P., Ternes, T. A., Trudeau, V. L., Boucard, T., Van Der Kraak, G. J. and Servos, M. R. (2010), Environmental risk assessment for the serotonin re-uptake inhibitor fluoxetine: Case study using the European risk assessment framework. Integr Environ Assess Manag, 6: 524–539. doi: 10.1002/ieam.77
- Issue online: 18 JUN 2010
- Version of Record online: 1 APR 2010
- Accepted manuscript online: 1 APR 2010 12:00AM EST
- Manuscript Accepted: 11 MAR 2010
- Manuscript Revised: 5 JAN 2010
- Manuscript Received: 25 NOV 2009
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.